chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Symptoms began at time of immunization. The patient complained of pain uin her left arm, not being able to lift her arm at all. Patient called the doctor 4 weeks after receiving the shot to ask if this was normal. The doctor stated that this "sometimes happens". Approximately 5 weeks after the immunization, patient said she could not lay on her side because it was very painful. The patient then told her pain management doctor who suggested she get a cat scan and an x-ray and suggested that maybe she had a disconnected shoulder. She saw her primary care doctor approximately 5 weeks ago who sent her to get an x-ray. The x-ray was normal. Her pain management doctor then suggested that it may be muscular and wrote her a prescription for a topical compound to apply to the area. She is currently waiting on the compound to be delivered. If the compound does not work, she will have to get a nerve conduction study to see if the needle hit a nerve. This test is very expensive and she is unsure if her insurance will pay for it.
48 hours after vaccine patient started aching in back, light headed, nausea, vomiting. Pain worsened in mid back-bil hand/arm neck stiffness.
they got cold chills; Nausea; a little bit of a headache; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (they got cold chills), NAUSEA (Nausea) and HEADACHE (a little bit of a headache) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Cancer and Diabetes.   On 14-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 14-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 20-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 21-Nov-2021, the patient experienced CHILLS (they got cold chills), NAUSEA (Nausea) and HEADACHE (a little bit of a headache). At the time of the report, CHILLS (they got cold chills), NAUSEA (Nausea) and HEADACHE (a little bit of a headache) outcome was unknown.            Patient is having chemotherapy.  Concomitant products included BP Medication and Diabetes medication.  No treatment was reported by the reporter.
Patient presented to Preventive Medicine with localized rash on right arm.  Tender and warm to the touch.  Swelling is present with rash spreading from shoulder down to elbow.
Employee recieved Fluad instead of Flulaval. Employee received flu vaccine on 10/13/2023. 10/14/2023 the employee experienced nausea and cramps. 10/23/2023 the cramps were so severe they went to the ED. No treatment was given during the ED visit. The employee's symptoms have resolved.
No additional adverse event reported; Customer called and reported that a dose of PROQUAD was administered to a 16 year old consumer.; This spontaneous report was received from a medical assistant and refers to a 16-year-old patient of unknown gender.  The patient's medical history, concurrent conditions and concomitant therapies were not reported.  On 07-JUL-2022, the 16-year-old patient was vaccinated with measles, mumps, rubella and varicella (oka-merck) virus vaccine live (rHA) (PROQUAD) (product administered to patient of inappropriate age) 0.5 milliliter (route of administration and anatomical location were not provided; lot #W010528, expiration date: 25-SEP-2023) for prophylaxis. No additional adverse event (AE) was reported. No additional information provided.
2nd dose received beyond 36 days; This spontaneous case was reported by a consumer and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (2nd dose received beyond 36 days) in a 74-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 006A21A and 012M20A) for COVID-19 vaccination.     The patient's past medical history included Broken leg and Surgery (The patient had 8 surgeries due to broken left leg before 1st dose) since an unknown date. Concurrent medical conditions included Diabetes (The patient reported a history of being diabetic) and Wheelchair user (The patient is confined to wheelchair).   On 10-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 22-Mar-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (2nd dose received beyond 36 days). On 22-Mar-2021, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (2nd dose received beyond 36 days) had resolved.            No concomitant medications were reported  No treatment information was provided   This case was linked to MOD-2021-416046 (Patient Link).
26 hours after shot, patient had a high fever it is was 101.2 whe first checked and it lasted 11 days and ranged from 99.1 to 101.2
Received on 01/03/2021 first COVID19 vaccine as Pfizer. Lot number is EL1284, and was administered intramuscular in left arm at 7:15 pm.  The second vaccine I was given was Moderna as seen in item 17. Was advised by Department of Health to report this incident.
Expired vaccine used; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) in a 35-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 17-Dec-2021 at 3:40 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On 17-Dec-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine used). On 17-Dec-2021, EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medications were not reported. Treatment medications were not reported.   Most recent FOLLOW-UP information incorporated above includes: On 17-Dec-2021: Follow up received includes reporter details
fever @ home 104.9, rash; started 7 days p/MMR; seen @ ER;
Significant loss of strength in right arm.  For example,  I have difficulty with simple, everysay tasks such as opening a jar or holding/ carrying my child when I was able to do so prior.  I also experience continous pain and discomfort in my right arm.
7NOV92 devel flushed face but remained active; 8NOV92 devel low grade fever & crankiness; started on APAP; 9NOV92 fever climbed to 102.5; also sore joints devel 10NOV92; pt refused fluids; because limp taken to ER;
his eyes are dry; nose is dry; if he blows his nose the mucous is bloody; his mouth is dry; his nose is still sore; Injection site swelling; Injection site pain; This is a spontaneous report from a contactable consumer (patient).  A 43-years-old male patient of an unspecified age received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot Number: EW01169 and expiration date was not reported) via an unspecified route of administration in left arm on 15Apr2021 (at the age of 43-years-old) as dose 1, single for COVID-19 immunization. The patient had no medical history and concomitant medications. On an unspecified date in Apr2021, the patient stated his eyes, nose and mouth were dry, if he blew the nose the mucous was bloody and had injection site swelling and pain. Patient stated his eyes were really dry, his nose had some bloodiness and was kind of dry too and that was all after he got the vaccine, was wondering if that was normal and was concerned. He confirms it was the Pfizer COVID vaccine. He clarifies if he blew his nose, there was not drainage, it was dry but the mucous has some blood in it. Patient thought it was 2-3 days later that he had swelling pain at the site, like pressure but he noticed the dry eyes and the issues with his nose about 3-4 later, he thought it was the 19 Apr 2021 or the 20 Apr 2021 because the swelling went down, and he noticed as the swelling went away the other symptoms came up on the face. Patient noticed that the dry eyes and bloody mucous were ongoing on the 19Apr2021 or the 20Apr2021 and then it took about a couple days for it to go away. Patient stated that was weird because his nose was not runny but in the mucous there was blood, his eyes and mouth were dry. Patient stated his dry eyes, dry mouth, dry nose and blood in the mucous were not 100 percent gone there was a little bit of mucous blood in the nose, his mouth, nose and eyes were still dry, nose was still sore, it was a little bit better, everything was still the same maybe little bit better, he clarified all of this with his eyes nose and mouth are ongoing but improved. Outcome of the events vaccination site swelling, vaccination site pain was recovered completely on an unspecified date in 2021, Patient stated it was gone, felt better. It hurted, a little bit and was tender to touch but other than that, it was fine, and the rest events were recovering.  No follow-up attempts are needed. No further information is expected.
Narrative:  Unclear what reaction patient had. It sounds as if patient may have had a vasovagal response to their Janssen covid vaccine. Reports having passed out with other vaccinations. It was not reported that patient needed any intervention.
No additional AEs/; the patient received ROTATEQ at 6 months.; the patient received ROTATEQ at 6 months; This spontaneous report was received from a physician, referring to a 6-month-old patient of unknown gender. The patient's medical history, concurrent conditions and concomitant medications were not reported.  Approximately in July 2022, the patient was vaccinated with the first dose of Rotavirus Vaccine, Live, Oral, Pentavalent (ROTATEQ), orally (dose, lot # and expiration date were not reported) for prophylaxis (inappropriate schedule of product administration, product administered to patient of inappropriate age). No additional adverse events were reported (no adverse event).
stroke after vaccine; This is a spontaneous report received from a non-contactable reporter(s) (Other HCP).  A male patient in his 60's (reported as 60-64 years) received BNT162b2 (BNT162B2), as dose number unknown (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (Primary immunization series complete; unknown manufacturer), for Covid-19 immunization. The following information was reported: CEREBROVASCULAR ACCIDENT (medically significant), outcome "unknown", described as "stroke after vaccine". Clinical course: Patient got his first booster and he was sort of throwing strokes. Patient experienced stroke after vaccine.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.; Sender's Comments: As there is limited information in the case provided, the causal association between the event and the suspect drug cannot be excluded. The case will be reassessed once new information is available.  The impact of this report on the benefit/risk profile of the Pfizer drug is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees, and Investigators, as appropriate.
The patient was seen 10/12/14 in Emergency Room with a swollen red painful left upper arm. He had a pneumonia shot and a tetanus shot in that arm on 10/10/14. That evening he began having shaking chills and malaise. His wife said that 10/11/14, he sat under a blanket all day because he was so cold. He had no fever. There is an area of cellulitis extending from 4 cm below the injection site under the arm and up to the top of the shoulder. The area is red and warm and tender. CBC was normal, Rocephin administered, also instructed to continue with Bactrim (taking for R hand infection-unrelated). Follow-up exam with PCP the 10/13/14 - no change in treatment.
Abruptly Monday night 1 week later injection site was overly itchy with several mosquito bite size bumps. Next day quarter size red mark that was hot and inflamed swollen arm with fever as high as 99.8. Fatigue, headache and general unwell. Wednesday severe joint pain. Arm is still red and inflamed. Photos available. Prescribed prednisone. Unclear if this is helping
Information has been received from a physician and a practice manager referring to a patient of unknown age and gender. On 12-APR-2016 the patient was vaccinated with an improperly stored dose of ROTATEQ oral dose, 10-pack (lot # K010224, expiration date 13-MAY-2016) orally. This specified lot number vaccine was exposed to temperature excursion twice. The total cumulative excursion time of the first time was 168 hours with the lowest recorded temperature of 0 Fahrenheit degree. The total cumulative excursion time of the second time was 992 hours with the lowest recorded temperature of 1.11 Fahrenheit degree. The storage criteria and the type of excursion for this vaccine was refrigerator (R). No adverse effect was reported. This is one of several reports received from the same source. Additional information has been requested.
first dose a year ago, has not received 2nd; This case was reported by a pharmacist via call center representative and described the occurrence of incomplete course of vaccination in a 72-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (received first dose a year ago).   On an unknown date, the patient did not receive the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.      Additional Information: GSK Receipt Date: 30-JUN-2022 Reporter's Comment:  Till the time of reporting, the patient did not receive 2nd dose of Shingrix, which led to incomplete course of vaccination. Additional supportive information: Till the time of reporting the patient did not receive the 2nd dose of Shingrix, which led to Incomplete course of vaccination. The vaccine administration facility was the same as primary reporter which corresponded to the 1st dose as 2nd dose was not administered. This case is linked to the case US2022099156, reported by the same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2022099156:Same reporter
Patient had no adverse events. Patient was accidently given a Moderna 0.5 dose for her booster instead of the 0.25 dose
Sore on her neck; Sore on her  back; Allergy; Rash; Hands went numb; Short of breath; Red; Welts; Sore on her arm; This spontaneous case was reported by a consumer and describes the occurrence of HYPOAESTHESIA (Hands went numb), DYSPNOEA (Short of breath), ERYTHEMA (Red), URTICARIA (Welts) and PAIN IN EXTREMITY (Sore on her arm) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event (no historical condition was reported). Concomitant products included VITAMIN C [ASCORBIC ACID], VITAMIN E NOS, VITAMIN D NOS, IRON, ZINC and PROBIOTICS NOS for an unknown indication.    On 19-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Feb-2021, the patient experienced HYPOAESTHESIA (Hands went numb), DYSPNOEA (Short of breath), ERYTHEMA (Red), URTICARIA (Welts), PAIN IN EXTREMITY (Sore on her arm), HYPERSENSITIVITY (Allergy) and RASH (Rash). On 20-Feb-2021, the patient experienced NECK PAIN (Sore on her neck ) and BACK PAIN (Sore on her  back). On 19-Feb-2021, HYPOAESTHESIA (Hands went numb) and DYSPNOEA (Short of breath) had resolved. At the time of the report, ERYTHEMA (Red), URTICARIA (Welts), HYPERSENSITIVITY (Allergy) and RASH (Rash) had resolved and PAIN IN EXTREMITY (Sore on her arm), NECK PAIN (Sore on her neck ) and BACK PAIN (Sore on her  back) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
1/7/2022 - 1/10/2022 (3 days) (Privacy)Hospital Patient is a 35 y.o. G3P2002 that presented to the hospital at 26wk0d gestation for fever.  Her prenatal course had been complicated by obesity, AMA, history of Caesarean section, and a language barrier.  Upon presentation she was noted to be febrile, tachycardic, and tachypneic.  She subsequently tested positive for COVID as well as had a UA that was concerning for urinary tract infection/pyelonephritis.  She was started on dexamethasone and remdesivir for her acute COVID as well as Rocephin for concern for pyelonephritis.  She denied any respiratory symptoms throughout her stay.  She clinically improved.  Her urine culture was positive for E coli.  Her antenatal fetal testing was reassuring.  She was discharged home in good condition on hospital day 3 on the Keflex for plan for a full 14 day treatment course followed by daily suppression
Took patient down for about a week./aching all over, joints and muscles too like the flu; flu-like symptoms; Took patient down for about a week./aching all over, joints and muscles too like the flu; Took patient down for about a week./aching all over, joints and muscles too like the flu; achiness; This is a spontaneous report from a contactable consumer or other non hcp. A 74-year-old male patient received first dose bnt162b2 BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; solution for injection, (Batch/Lot Number: EN6200; Expiration Date: Jun2021)), via an unspecified route of administration, administered in Arm Left on 26Feb2021(at the age of 74-year-old) as, Single for COVID-19 immunization. Medical history included arthritis from 2017 to 2018 arthritis is in his right foot only and his big toe. The patient's concomitant medications were not reported. He received the 1st dose on 26Feb2021 and the 2nd dose on 19Mar2021. She mentioned that both of them experienced achiness after the 1st dose and flu-like symptoms after both doses. Her husband however, had muscle weakness on his legs after the 2nd dose. On 13Apr2021, about 3 weeks and 4 days after the 2nd dose, her husband received a steroid shot on his right foot. They noticed that the weakness on his legs became extreme, to which he had trouble standing up and has to hold on to something to stand up as he cannot support himself. He also had a rash on his trunk, back, and down his arms. She mentioned that the rash was not itchy but was speckled like measles. They are wondering if this has been reported and if it is possibly an interaction between the vaccine and steroid. The patient experienced took patient down for about a week/aching all over, joints and muscles too like the flu on 26Feb2021 and achiness, flu-like symptoms. The patient underwent lab tests and procedures which included covid-19 was Negative on 19Apr2021. The outcome of the events pain and Influenza like illness was recovered on 03Mr2021 and unknown for other events.  No follow-up attempts are needed. No further information is expected
Systemic: Dizziness / Lightheadness-Medium, Systemic: Fainting / Unresponsive-Medium, Systemic: Flushed / Sweating-Medium, Systemic: Headache-Medium, Systemic: Hypotension-Medium, Additional Details: Patient received 2 vaccines in the left arm IM. She stood up too fast and started feeling light headed. She passed out for a few seconds. I immediately called for the PA to assist as her friend and myself pulled her up after fainting. She told me afterwards that she tends to faint after receiving vaccinations. She regained consciousiness. Her BP was checked by the PA 3 different times and increased over 45 minutes to 1 hour. She rested with her feet raised and felt better after drinking water.
Information has been received via Novartis (manufacturer control # S2009US02845), from a female that received a dose of PNEUMOVAX (manufacturer unknown) in 2004, that caused pain in her arms for years. No further information is available.
On 1/29/2021 around 4am I woke up vomiting. I felt nauseas, weakness, chills & sever migraines. I was not able to eat all this symptoms lasted for 24hrs.
Information has been received from a pharmacist concerning a 26 year old female who on 16-MAR-2007 was vaccinated with the first dose of Gardasil. Concomitant therapy included ZYRTEC. On 16-MAR-2007 the patient experienced itching and the sensation that her throat was closing up after taking an unspecified antihistamine. Medical attention was sought. Additional information has been requested.
After about 3 minutes of patient sitting, she complained of feeling nauseous, warm, light-headed. We gave water, and trash can but patient became unresponsive and blacked out.   We called 911.   Patient came to within a matter of seconds.  She progressively got better and was conversating.   EMS checked her vitals and all were fine.  She refused going to the hospital and was taken home by a relative.   No information given on pregnancy.
Lightheaded spells beginning on day after shot. Accompanied by frequent heart palpitations that some times left me breathless or feeling very out of it.
The patient was given a high dose flu shot on 10/9/20 around 11:50am. The patient called me at 3:50pm letting me know that she is having excessive swelling ("goose-egg", "half baseball-size") around the injection site. I asked the patient if she was having any other symptoms (shortness of breath, hives) but she denied these and stated that she may be feeling a little flushed. She mentioned that this was her first high-does flu shot since she just turned 65 this past September. I advised her to place an ice-pack on the swollen area (for 15-minute intervals) and to take ibuprofen to help with the swelling. The patient also took a Benadryl tablet. The patient does have a latex allergy but I made sure to use the Nitrile gloves and Latex-free bandage when giving the immunization. I called the patient to follow up on symptoms 30 minutes later and she said that she is still feeling fine overall just still has the "goose-egg" swelling. Advised her to call us with any changes.
Information has been received from a female consumer who on an unspecified date was vaccinated with a dose MMR II (Lot not reported) and later she discovered she was pregnant. Subsequently, the patient experienced "every reaction possible". She continued to have unspecified problems on 03-APR-2009, which are believed to be based on the rubella component. At the time of reporting (03-APR-2009) the outcome of the patient was unknown. No further information is available.
On Friday 8/11/2017 patient had the MMRV vaccination given subcutaneously in her left arm. On Saturday morning there were some blisters forming, some redness, and it was warm to the touch. Patient had a fever of 100.6, that was resolved with Motrin. To monitor the redness/swelling I drew a circle around the area. On Sunday morning the blisters were open. The redness and swelling spread beyond the circle almost extending from her shoulder to elbow. At that point I brought her in to the E.R. to be evaluated. The Doctor examined her arm and determined that she had cellulitis caused by the injection. He ordered Keflex three times a day for 7 days. Today, Friday 8/18/2017 the injection site looks much better. The redness and swelling is gone and the blisters are healing up nicely.